Conclusion Gradually increasing the semaglutide dose lets the body adjust and may lower the chance of side effects
In the SCALE Diabetes trial, participants with type 2 diabetes were given either 1.8 mg of liraglutide, 3 mg of liraglutide, or a placebo
Op-ed: Toolkit: #statepolicy #pharma #biotech #innovation #340B #PDAB #raredisease To view or add a comment, sign in In March 2026, the FDA introduced one of its most significant reforms to #biosimilarregulation to date
Do not increase or stop medications without clinician's approval
Retatrutide does not, yet
When you understand that, you can prepare for it instead of being discouraged by it. Hill and Wyatt have published a new book designed to help people successfully navigate life after GLP-1s: Losing the Weight Loss Meds: A 10-Week Playbook for Stopping GLP1 Medications Without Regaining the Weight. We wrote this book because the medical system is good at helping people lose weight, but far less prepared to guide them through maintenance, Wyatt said